Published: September 2025

Last updated: October 2025

Recommended Data Standards for Managing and Reporting Missing Utility Data for Health Technology Appraisal

Panel Presentation at the Royal Statistical Society Conference 2025

OBJECTIVES: Health Technology Assessment (HTA) guidelines in the UK mention the importance of uncertainty in cost-effectiveness analysis (CEA). The presence of missing data within data sets used to provide inputs for CEA can be a source of uncertainty. One setting in which missing data may be prevalent is for utility scores and these are often used in CEA. The intention of this analysis is to formalise recommendations for dealing with missingness and outline a minimum accepted reporting standard for missing utility data.

METHODS: A simulated patient level dataset (SIPD) was created in an oncology setting. The SIPD included utility scores for hypothetical individuals and treatments. Key prognostic variables were also simulated. Missing data was generated for utility for 10% and 30% of the observations, for missing completely at random (MCAR), at random (MAR) and not at random (MNAR) missingness mechanisms. Four methods for addressing missing data were analysed, complete case analysis (CCA), mean score estimation (MSE), multiple imputation via chained equations (MICE) and linear mixed modelling (LMM). The outcome of interest was the mean difference between the true utility value and the estimated utility value from each method.

RESULTS: MICE tended to result in the lowest mean difference across levels and mechanism. For the 10% level and MCAR mechanism, CCA resulted in negligible differences from the true utility value. MNAR data tended to result in substantial differences from the true utility value regardless of the level of missingness and method used. LMMs suppressed the standard deviation of utility.

CONCLUSION: Differing results across levels and mechanisms for each method used to deal with missingness were observed here. This suggest that the level and mechanism of missingness should be investigated and reported as a minimum standard for all data sets that inform economic models for HTA in the UK.

You may also be interested in

Peer-reviewed publication

The Economic and Clinical Impact of an AI-Assisted Tool for Colonoscopy to Support Diagnosis of Colorectal Cancer in Symptomatic Patients in England

YHEC authors: Luc Curtis-Gretton, Angel Varghese, Karina Watts, Hayden Holmes
Publication date: November 2026
Publishers: Springer Nature Link
Journal: BMC Digital Health

Abstract

BACKGROUND: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality in the UK. Early detection and removal of adenomatous polyps are essential to improving outcomes. Artificial intelligence-assisted colonoscopy tools,...

Peer-reviewed publication

Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Asymptomatic Severe Aortic Stenosis in the Kingdom of Saudi Arabia

YHEC authors: Madison Montgomery, Heather Davies, Lucy Hillcoat
Publication date: October 2026
Journal: Frontiers in Cardiovascular Medicine

Abstract

INTRODUCTION: Aortic stenosis (AS) is defined as the narrowing of the aortic valve. The benefits of implementing early aortic valve replacement (AVR), while the AS is asymptomatic, have been demonstrated...

Peer-reviewed publication

What is the Role of Multidisciplinary Methods to Support Environmental Sustainability in Health Technology Assessment?

YHEC authors: Melissa Pegg, Emma Bishop, Karina Watts
Publication date: October 2026
Publishers: HTAi
Journal: International Journal of Technology Assessment in Healthcare

Abstract

Healthcare contributes up to 8.5 percent of global carbon emissions, amongst other environmental impacts including intensive water consumption, plastics in our environment and pharmaceutical associated pollution. Healthcare supply chains are...